On October 24, Gu Bing, Party Secretary and Executive Vice Chairman of the Association for Science and Technology of Pudong New District, and other leaders visited Yuanvore Medicine University to carry out research and guidance work.

Recently, a number of inclusive financial advisers from the Shanghai Financial Industry Association visited Yuanvore Medicine in person to provide face-to-face financial advisory services!

On January 13, 2024, Yuanvore Medicine "Yuanvore Ying Chen Long journey" New Year appreciation party was successfully held, the company's leaders, all employees, and guests gathered to celebrate.

On January 3, 2024, the Yuanvore Medicine Stem Cell Engineering Technology Center was officially opened, and the unveiling ceremony was held at the same time.

Recently, Yuanvore Medicine Pathogenic Microbiology Laboratory successfully passed the BSL-2 registration certification, that is, P2 laboratory certification.

n Ouyang Ping's view, this technology has developed to a rare window period.

Shanghai Yuanvore Medicine Technology Co., Ltd. is a regenerative medicine company specializing in the development and application of iPSC (induced pluripotent stem cells) technology.